Market Cap 170.85M
Revenue (ttm) 4.35M
Net Income (ttm) -45.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,046.67%
Debt to Equity Ratio 3.22
Volume 636,600
Avg Vol 1,343,450
Day's Range N/A - N/A
Shares Out 133.48M
Stochastic %K 76%
Beta 1.19
Analysts Strong Sell
Price Target $3.75

Company Profile

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths th...

Industry: Medical Devices
Sector: Healthcare
Phone: 917 813 1828
Address:
360 Madison Avenue, 25th Floor, New York, United States
xx007xx
xx007xx Oct. 27 at 9:29 PM
$LUCD years of psychotic behavior…not healthy…
0 · Reply
PortfolioMgmt23
PortfolioMgmt23 Oct. 27 at 7:05 PM
$LUCD @dmc4321 is posting a TON OF NEGATIVITIY. I can't ask for a better sign that GOOD NEWS is just ahead!
0 · Reply
dmc4321
dmc4321 Oct. 27 at 3:28 PM
$LUCD Last part got cut off.
1 · Reply
dmc4321
dmc4321 Oct. 27 at 3:09 PM
$LUCD People think that Companies buy Companies, They do NOT. People buy Companies. A single person or a very small group of people make the decision to buy a Company and for how much. They know there own future is at RISK. Their Competitors within the company want them to fail and will highlight if "Joe Bloggs OVERPAID" or made an "UNNECESSARY acquisition". If that is seen as true that individual or small group's future wealth and promotions will be VERY NEGATIVELY affected. They will not be trusted with potential deals of the same size and DEFINITELY not deals that are more strategic. So the fact that Lishan and Dennis have FAILED to launch ALL 5 products they have attempted MATTERS. That they have no Sales and Marketing TALENT MATTERS That $LUCD is broke in the Summer of 2026 MATTERS. That LUCD only managed to sell 1,000 EsoGuard tests to "CMS Covered Patients" in the first 6 MONTHS of 2025 (DESPITE having nearly 30 Sales People for OVER 5 years) REALLY MATTERS
0 · Reply
tds_
tds_ Oct. 27 at 1:13 PM
$LUCD NVS dropping $12 billion for RNA. A lot of big pharma money sloshing around out there....
1 · Reply
Ironbow
Ironbow Oct. 26 at 8:11 PM
$LUCD Dave…: Drink a beer, watch some football 🏈 …..You’re going to have a stroke //~
0 · Reply
dmc4321
dmc4321 Oct. 25 at 1:30 PM
$LUCD @oaksapollo Oaksapollo is lying again but his basic math is also sketchy. I cant be bothered to pick apart the MULTIPLE lies but will let you see how EVEN the BASIC Math is wrong. He said "A 36% growth rate would put Esoguard test volume at about 19,000 Q4 2026, close to $37M in revenue. Fully diluted with a revenue multiple of 6 (mean for biotech) you get a share price of around $4." Fully diluted TODAY there are 230 Million shares outstanding and LUCD is BROKE Summer 2026 so ANOTHER raise is "IMMINENT" 🤩 But we will ignore that! So 19,000 EsoGuard tests inQ4 2026 times $1983 per EsoGuard tests is actually close to $38 Million in Revenue Multiplied by Revenue Multiple of 6 is 😜 228,000,000 BUT we must DIVIDE by the FULLY DILUTED SHARE COUNT of 230,000,000 (its a little more!!😱😱😱) to gives us a share price of 99 CENTS 😱😱😱. 99 CENTS 😱😱😱. 99 CENTS 😱😱😱. 99 CENTS 😱😱😱. 99 CENTS 😱😱😱. 99 CENTS
2 · Reply
oaksapollo
oaksapollo Oct. 25 at 5:31 AM
$LUCD What do you guys think is a reasonable number for average Q/Q test volume growth next year? Here are Cologuard numbers the first 2 years after launch: Q1 2015: 11K Q2: 21K Q3: 34K Q4: 38K Q1 2016: 40K Q2: 50K Q3: 68K Q4: 82K If you average the Q/Q growth rates, you get 36%. Keep in mind Cologuard got Medicare coverage in late 2014. A 36% growth rate would put Esoguard test volume at about 19,000 Q4 2026, close to $37M in revenue. Fully diluted with a revenue multiple of 6 (mean for biotech) you get a share price of around $4. Now consider: -Exact's revenue multiple in 2015 was over 20. -Uptake of Esoguard could be much faster than Cologuard because GI practices are already embracing it, whereas GIs fought Cologuard initially. If I plug in 45% Q/Q growth on average and a rev multiple of 10 (still half of Exact's in 2015), now the share price is $9 end of next year. Say growth is 60%, rev multiple 15, now it's $22. Any thoughts on how fast they can grow test vol?
2 · Reply
mlwtwits
mlwtwits Oct. 24 at 9:26 PM
$LUCD 💲✅💲
0 · Reply
DonWanSan
DonWanSan Oct. 24 at 9:25 PM
$LUCD any price predictions on this?
2 · Reply
Latest News on LUCD
Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 4:39 PM EDT - 2 months ago

Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript


Lucid Diagnostics Inc. (LUCD) Q4 2024 Earnings Call Transcript

Mar 24, 2025, 12:17 PM EDT - 7 months ago

Lucid Diagnostics Inc. (LUCD) Q4 2024 Earnings Call Transcript


xx007xx
xx007xx Oct. 27 at 9:29 PM
$LUCD years of psychotic behavior…not healthy…
0 · Reply
PortfolioMgmt23
PortfolioMgmt23 Oct. 27 at 7:05 PM
$LUCD @dmc4321 is posting a TON OF NEGATIVITIY. I can't ask for a better sign that GOOD NEWS is just ahead!
0 · Reply
dmc4321
dmc4321 Oct. 27 at 3:28 PM
$LUCD Last part got cut off.
1 · Reply
dmc4321
dmc4321 Oct. 27 at 3:09 PM
$LUCD People think that Companies buy Companies, They do NOT. People buy Companies. A single person or a very small group of people make the decision to buy a Company and for how much. They know there own future is at RISK. Their Competitors within the company want them to fail and will highlight if "Joe Bloggs OVERPAID" or made an "UNNECESSARY acquisition". If that is seen as true that individual or small group's future wealth and promotions will be VERY NEGATIVELY affected. They will not be trusted with potential deals of the same size and DEFINITELY not deals that are more strategic. So the fact that Lishan and Dennis have FAILED to launch ALL 5 products they have attempted MATTERS. That they have no Sales and Marketing TALENT MATTERS That $LUCD is broke in the Summer of 2026 MATTERS. That LUCD only managed to sell 1,000 EsoGuard tests to "CMS Covered Patients" in the first 6 MONTHS of 2025 (DESPITE having nearly 30 Sales People for OVER 5 years) REALLY MATTERS
0 · Reply
tds_
tds_ Oct. 27 at 1:13 PM
$LUCD NVS dropping $12 billion for RNA. A lot of big pharma money sloshing around out there....
1 · Reply
Ironbow
Ironbow Oct. 26 at 8:11 PM
$LUCD Dave…: Drink a beer, watch some football 🏈 …..You’re going to have a stroke //~
0 · Reply
dmc4321
dmc4321 Oct. 25 at 1:30 PM
$LUCD @oaksapollo Oaksapollo is lying again but his basic math is also sketchy. I cant be bothered to pick apart the MULTIPLE lies but will let you see how EVEN the BASIC Math is wrong. He said "A 36% growth rate would put Esoguard test volume at about 19,000 Q4 2026, close to $37M in revenue. Fully diluted with a revenue multiple of 6 (mean for biotech) you get a share price of around $4." Fully diluted TODAY there are 230 Million shares outstanding and LUCD is BROKE Summer 2026 so ANOTHER raise is "IMMINENT" 🤩 But we will ignore that! So 19,000 EsoGuard tests inQ4 2026 times $1983 per EsoGuard tests is actually close to $38 Million in Revenue Multiplied by Revenue Multiple of 6 is 😜 228,000,000 BUT we must DIVIDE by the FULLY DILUTED SHARE COUNT of 230,000,000 (its a little more!!😱😱😱) to gives us a share price of 99 CENTS 😱😱😱. 99 CENTS 😱😱😱. 99 CENTS 😱😱😱. 99 CENTS 😱😱😱. 99 CENTS 😱😱😱. 99 CENTS
2 · Reply
oaksapollo
oaksapollo Oct. 25 at 5:31 AM
$LUCD What do you guys think is a reasonable number for average Q/Q test volume growth next year? Here are Cologuard numbers the first 2 years after launch: Q1 2015: 11K Q2: 21K Q3: 34K Q4: 38K Q1 2016: 40K Q2: 50K Q3: 68K Q4: 82K If you average the Q/Q growth rates, you get 36%. Keep in mind Cologuard got Medicare coverage in late 2014. A 36% growth rate would put Esoguard test volume at about 19,000 Q4 2026, close to $37M in revenue. Fully diluted with a revenue multiple of 6 (mean for biotech) you get a share price of around $4. Now consider: -Exact's revenue multiple in 2015 was over 20. -Uptake of Esoguard could be much faster than Cologuard because GI practices are already embracing it, whereas GIs fought Cologuard initially. If I plug in 45% Q/Q growth on average and a rev multiple of 10 (still half of Exact's in 2015), now the share price is $9 end of next year. Say growth is 60%, rev multiple 15, now it's $22. Any thoughts on how fast they can grow test vol?
2 · Reply
mlwtwits
mlwtwits Oct. 24 at 9:26 PM
$LUCD 💲✅💲
0 · Reply
DonWanSan
DonWanSan Oct. 24 at 9:25 PM
$LUCD any price predictions on this?
2 · Reply
oaksapollo
oaksapollo Oct. 24 at 8:41 PM
$LUCD Big drop in short interest 10/15 (just out). https://www.nasdaq.com/market-activity/stocks/lucd/short-interest
1 · Reply
BlameTheBartender
BlameTheBartender Oct. 24 at 8:26 PM
$LUCD Great day..hopefully we get news next week-I think we all know it will be just days or weeks not some other bs from paid negative shills
0 · Reply
RagusDogMack
RagusDogMack Oct. 24 at 7:44 PM
$LUCD Thank you all for participating in my investor poll. The results are in. Consensus is for Draft LCD coverage within 2 months, and final approval by mid-2026, in about 8 months.
3 · Reply
PortfolioMgmt23
PortfolioMgmt23 Oct. 24 at 3:57 PM
$LUCD Make them COVER!
0 · Reply
quegoalasoche
quegoalasoche Oct. 24 at 3:56 PM
$PAVM $LUCD https://m.facebook.com/watch/?v=1228769485722569&vanity=2822news
0 · Reply
minnesotafarmcountry
minnesotafarmcountry Oct. 24 at 2:10 PM
$LUCD 🤩
1 · Reply
Ironbow
Ironbow Oct. 24 at 1:48 PM
$LUCD Dave / dmc / LPlates‘s talking points are all BS. 👇🏻
0 · Reply
LPlates
LPlates Oct. 24 at 3:10 AM
I've said that $LUCD is out of money Summer of 2026 and must raise $100M+. Lishan and Dennis are hungry little piggie's and will dilute and dilute and dilute both $PAVM and LUCD. They need to keep getting $30K EACH a month from BOTH companies. Each get paid $720K plus benefits and expenses which is a top 1% lifestyle for a bottom 1% performance. They don't care about dilution and what price it's done at. They only care to gorge themselves like the fat little 🐖🐷🐖🐷 piggies they are on LUCD and PAVM So no bankruptcy but MASSIVE DILUTION
1 · Reply
KYLE0829
KYLE0829 Oct. 23 at 11:22 PM
$LUCD does the transcript of the meeting have to be posted x amount of days prior to decision or do you think more of a formality and could be a day before?
2 · Reply
oaksapollo
oaksapollo Oct. 23 at 10:10 PM
$LUCD in just 3 weeks it will be Q3 results time. I sure hope we have an LCD prior to then or it's going to be a painful call.
1 · Reply
dmc4321
dmc4321 Oct. 23 at 7:09 PM
$LUCD Here is a ChatGPt link that basically says it can be as soon as IMMEDIATE or can be 60 days or more https://chatgpt.com/s/t_68fa7d22ad588191aecca573cea2bee0
0 · Reply
Lets_Go_Brndn
Lets_Go_Brndn Oct. 23 at 6:37 PM
$LUCD $PAVM Crystal Ball story: LPlates died. His granddaughter asked his mom, “Will I ever see LPlates again?” His mom said: “Not if you’re good”. 😊
1 · Reply